Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-25 @ 9:27 PM
Study NCT ID:
NCT00694356
Status:
COMPLETED
Last Update Posted:
2018-08-08
First Post:
2008-05-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-04
Start Date Type:
ACTUAL
Primary Completion Date:
2009-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04-28
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-29
First Submit QC Date:
None
Study First Post Date:
2008-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-28
Results First Submit QC Date:
None
Results First Post Date:
2017-06-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-12
Last Update Post Date:
2018-08-08
Last Update Post Date Type:
ACTUAL